Cancer Channel
Related Channels

Adcetris and Lymphoma

Adcetris™ (brentuximab vedotin) is a lymphoma treatment that may help kill cancer cells and reduce tumor size. Specifically, this chemotherapy drug is approved to treat Hodgkin's lymphoma and a type of non-Hodgkin's lymphoma called systemic anaplastic large cell lymphoma (ALCL). It is approved for use in adults only and is reserved for use after other treatments have been unsuccessful.
There are also occasions where a healthcare provider may prescribe Adcetris for treating other types of lymphoma, leukemia, and multiple myeloma. However, these are unapproved, or "off-label," uses for Adcetris.
(For more detailed information this lymphoma treatment, including how it works and why it is not approved for use in children, click Adcetris Uses.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.